F I Ershov,N V Kasianova,A N Vasilev
F I Ershov
N V Beloborodova
N V Beloborodova
[Current possibilities and perspectives of the combined treatment of patients with severe bronchopulmonary diseases] [0.03%]
[严重支气管肺疾病的综合治疗的现状和前景]
V I Sokolova,V A Shenderovich,V A Orlov et al.
V I Sokolova et al.
Complex treatment with ceftriaxone (or ceftazidime) and intravenous immunoglobulin G (Biaven V. I.) was performed at 21 patients with severe pneumonia and tracheobronchitis complicated by immunedeficient status (myasthenia, diabetes mellitu...
[Dynamics of antibiotic resistance of purulent septic pathogens at an emergency facility] [0.03%]
[急诊病原菌脓毒症细菌耐药性动态变化分析]
D D Menshikov,N V Evdokimova,I V Grunenkova et al.
D D Menshikov et al.
The predominant pathogens at the emergency medicine hospital were analysed and its resistance to antibiotics was investigated in dynamics. The susceptibility of the pathogens was analysed by the method of dynamic equalibration. Statisticall...
[Ani immunomodulator Hepon inhibits hepatitis C virus replication in human cell cultures in vitro] [0.03%]
抗免疫调节剂希邦抑制丙型肝炎病毒的人体细胞系中的病毒复制
R I Ataullakhanov,R D Holms,A V Katlinskiĭ et al.
R I Ataullakhanov et al.
Antiviral activity of immunomodulator "Hepon" was evaluated in human cells culture infected with hepatitis C virus. "Hepon" presence protected human cells SW-13 from cytopathogenic effect of hepatitis C virus. Maximum antiviral effect was d...
[Functional activity of ABC transporters (markers of multidrug resistance) in human colon adenocarcinoma and normal colonic mucosa] [0.03%]
人结肠黏膜和结肠腺癌中ABC转运蛋白(多药耐药性标志物)的功能活性
E A Bogush,A B Ravcheeva,A V Konukhova et al.
E A Bogush et al.
Functional activity of multidrug resistance (MDR) markers (total activity of ABC-transporters, P-glycoprotein (Pgp) and multidrug resistance-associated protein (MRP) activities) in human colon adenocarcinoma and normal mucosa was examined. ...
Comparative Study
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 2002;47(8):3-8. DOI: 2002
[Fluoroquinolones as antibacterial preparations and their use in the treatment of tuberculosis] [0.03%]
氟喹诺酮类抗菌制剂及其用于治疗结核病的应用
E B Vishnevskaia,V I Kocherovets,B I Vishnevskiĭ
E B Vishnevskaia
[Fibrin-collagen substance as a vehicle for local application of antibacterial agents] [0.03%]
富含纤维蛋白的凝血酶止血 sponge作为局部抗菌剂载体的研究
V A Gorskiĭ,A A Gertsog,I V Leonenko et al.
V A Gorskiĭ et al.
Inhibitory activity of fibrin-collagen substance (FCS) impregnated by various antibacterial agents against various microorganisms was investigated. It was demonstrated that antibacterials bind well with FCS, providing its sufficient antibac...
[Sensitivity to levofloxacin of various types of non-tuberculosis Mycobacterium] [0.03%]
不同类型的非结核分枝杆菌对左氧氟沙星的敏感性研究
T F Otten,N S Soloveva,B I Vishnevskiĭ
T F Otten
Activity of levofloxacin (Tavanic) against 10 species of nontuberculosis of mycobacteria was investigated by indirect method of absolute concentrations on Levenstain-Jensen media (levofloxacin concentration 5 and mcg/mL). The investigation ...
[Sensitivity to levofloxacin of Mycobacterium tuberculosis strains with various phenotype isolated from patients with newly diagnosed and chronic tuberculosis] [0.03%]
[利福平各种耐药表型的新发和慢性感染肺结核分离株中左氧氟沙星敏感性研究]
B I Vishnevskiĭ,O V Narvskaia,I V Mokrousov et al.
B I Vishnevskiĭ et al.
Susceptibility to levofloxacin of 56 strains of Mycobacterium tuberculosis, isolated from 22 patients with first estimated and 84 patients with chronic tuberculosis was investigated. Ratio of multi-drug resistance achieved 54.5 per cent in ...